News

Debiopharm said Debio 1142 project aims at developing inhibitors targeting a key oncology pathway, which plays essential roles in various solid tumours, including resistance to chemotherapy. Aurigene CEO

Resminostat is currently being evaluated in Phase II trials by 4SC in hepatocellular carcinoma (HCC), Hodgkin lymphoma (HL) and colorectal cancer in KRAS-mutant patients (CRC). As per the

Dr Reddy’s will market the product under store brand labels in the US market. OTC fexofenadine HCl tablets are the generic version of Sanofi-aventis’ Allegra tablets, which received

Tripos provides scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Certara focuses on reducing the barriers between the phases of research to speed

Bio-T-Gel, a treatment for low testosterone levels in males, was initially developed by BioSante Pharma, and then was licensed to Teva for further development. As per the licensing

IRMS|360 is a fully interoperable, public health emergency response solution to connect disparate data systems into a single, secure enterprise database repository, providing real-time actionable intelligence from the

In the trial, the patients were titrated to an optimal dose of rotigotine (0.5-4.0 T mg/24h) and periodically evaluated for safety and efficacy. Of the 295 patients in

PRT-201 is an investigational recombinant human elastase that is being studied for its ability to improve arteriovenous fistula (AVF) and arteriovenous graft (AVG) outcomes in patients requiring chronic

As per the agreement, Quest and Hemispherx will equally share the clinical trial’s expenses. Hemispherx will offer technical expertise and relevant data to support the regulatory process necessary